8
|
Alam NA, Bevan S, Churchman M, Barclay E, Barker K, Jaeger EEM, Nelson HM, Healy E, Pembroke AC, Friedmann PS, Dalziel K, Calonje E, Anderson J, August PJ, Davies MG, Felix R, Munro CS, Murdoch M, Rendall J, Kennedy S, Leigh IM, Kelsell DP, Tomlinson IPM, Houlston RS. Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3-q43. Am J Hum Genet 2001; 68:1264-9. [PMID: 11283798 PMCID: PMC1226106 DOI: 10.1086/320124] [Citation(s) in RCA: 85] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2001] [Accepted: 02/28/2001] [Indexed: 11/03/2022] Open
Abstract
Dominant transmission of multiple uterine and cutaneous smooth-muscle tumors is seen in the disorder multiple leiomyomatosis (ML). We undertook a genomewide screen of 11 families segregating ML and found evidence for linkage to chromosome 1q42.3-q43 (maximum multipoint LOD score 5.40). Haplotype construction and analysis of recombinations permitted the minimal interval containing the locus, which we have designated "MCUL1," to be refined to an approximately 14-cM region flanked by markers D1S517 and D1S2842. Allelic-loss studies of tumors indicated that MCUL1 may act as a tumor suppressor. Identification of MCUL1 should have wide interest, since this gene may harbor low-penetrance variants predisposing to the common form of uterine fibroids and/or may undergo somatic mutation in sporadic leiomyomata.
Collapse
Affiliation(s)
- N. A. Alam
- Molecular and Population Genetics Laboratory and Skin Tumour Laboratory, Imperial Cancer Research Fund, Royal London Hospital, and Department of Dermatopathology, St. John's Institute of Dermatology, St. Thomas's Hospital, London; Section of Cancer Genetics, Haddow Laboratories, Institute of Cancer Research, Sutton, United Kingdom; Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford; Department of Dermatology, Queen's Hospital, Burton-on-Trent, United Kingdom; Department of Dermatopharmacology, Southampton University, Southampton, United Kingdom; Department of Dermatology, Orpington Hospital, Orpington, United Kingdom; Department of Dermatology, Queen's Medical Centre, Nottingham; Department of Dermatology, The Queen Elizabeth Hospital, Peterborough, United Kingdom; Department of Dermatology, Leighton Hospital, Crewe, United Kingdom; Summerleas, Yelverton, United Kingdom; Department of Dermatology, Frimley Park Hospital, Frimley, United Kingdom; Department of Dermatology, Southern General Hospital, Glasgow; Department of Dermatology, Watford General Hospital, Watford, United Kingdom; and Department of Dermatology, The County Hospital, Hereford, United Kingdom
| | - S. Bevan
- Molecular and Population Genetics Laboratory and Skin Tumour Laboratory, Imperial Cancer Research Fund, Royal London Hospital, and Department of Dermatopathology, St. John's Institute of Dermatology, St. Thomas's Hospital, London; Section of Cancer Genetics, Haddow Laboratories, Institute of Cancer Research, Sutton, United Kingdom; Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford; Department of Dermatology, Queen's Hospital, Burton-on-Trent, United Kingdom; Department of Dermatopharmacology, Southampton University, Southampton, United Kingdom; Department of Dermatology, Orpington Hospital, Orpington, United Kingdom; Department of Dermatology, Queen's Medical Centre, Nottingham; Department of Dermatology, The Queen Elizabeth Hospital, Peterborough, United Kingdom; Department of Dermatology, Leighton Hospital, Crewe, United Kingdom; Summerleas, Yelverton, United Kingdom; Department of Dermatology, Frimley Park Hospital, Frimley, United Kingdom; Department of Dermatology, Southern General Hospital, Glasgow; Department of Dermatology, Watford General Hospital, Watford, United Kingdom; and Department of Dermatology, The County Hospital, Hereford, United Kingdom
| | - M. Churchman
- Molecular and Population Genetics Laboratory and Skin Tumour Laboratory, Imperial Cancer Research Fund, Royal London Hospital, and Department of Dermatopathology, St. John's Institute of Dermatology, St. Thomas's Hospital, London; Section of Cancer Genetics, Haddow Laboratories, Institute of Cancer Research, Sutton, United Kingdom; Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford; Department of Dermatology, Queen's Hospital, Burton-on-Trent, United Kingdom; Department of Dermatopharmacology, Southampton University, Southampton, United Kingdom; Department of Dermatology, Orpington Hospital, Orpington, United Kingdom; Department of Dermatology, Queen's Medical Centre, Nottingham; Department of Dermatology, The Queen Elizabeth Hospital, Peterborough, United Kingdom; Department of Dermatology, Leighton Hospital, Crewe, United Kingdom; Summerleas, Yelverton, United Kingdom; Department of Dermatology, Frimley Park Hospital, Frimley, United Kingdom; Department of Dermatology, Southern General Hospital, Glasgow; Department of Dermatology, Watford General Hospital, Watford, United Kingdom; and Department of Dermatology, The County Hospital, Hereford, United Kingdom
| | - E. Barclay
- Molecular and Population Genetics Laboratory and Skin Tumour Laboratory, Imperial Cancer Research Fund, Royal London Hospital, and Department of Dermatopathology, St. John's Institute of Dermatology, St. Thomas's Hospital, London; Section of Cancer Genetics, Haddow Laboratories, Institute of Cancer Research, Sutton, United Kingdom; Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford; Department of Dermatology, Queen's Hospital, Burton-on-Trent, United Kingdom; Department of Dermatopharmacology, Southampton University, Southampton, United Kingdom; Department of Dermatology, Orpington Hospital, Orpington, United Kingdom; Department of Dermatology, Queen's Medical Centre, Nottingham; Department of Dermatology, The Queen Elizabeth Hospital, Peterborough, United Kingdom; Department of Dermatology, Leighton Hospital, Crewe, United Kingdom; Summerleas, Yelverton, United Kingdom; Department of Dermatology, Frimley Park Hospital, Frimley, United Kingdom; Department of Dermatology, Southern General Hospital, Glasgow; Department of Dermatology, Watford General Hospital, Watford, United Kingdom; and Department of Dermatology, The County Hospital, Hereford, United Kingdom
| | - K. Barker
- Molecular and Population Genetics Laboratory and Skin Tumour Laboratory, Imperial Cancer Research Fund, Royal London Hospital, and Department of Dermatopathology, St. John's Institute of Dermatology, St. Thomas's Hospital, London; Section of Cancer Genetics, Haddow Laboratories, Institute of Cancer Research, Sutton, United Kingdom; Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford; Department of Dermatology, Queen's Hospital, Burton-on-Trent, United Kingdom; Department of Dermatopharmacology, Southampton University, Southampton, United Kingdom; Department of Dermatology, Orpington Hospital, Orpington, United Kingdom; Department of Dermatology, Queen's Medical Centre, Nottingham; Department of Dermatology, The Queen Elizabeth Hospital, Peterborough, United Kingdom; Department of Dermatology, Leighton Hospital, Crewe, United Kingdom; Summerleas, Yelverton, United Kingdom; Department of Dermatology, Frimley Park Hospital, Frimley, United Kingdom; Department of Dermatology, Southern General Hospital, Glasgow; Department of Dermatology, Watford General Hospital, Watford, United Kingdom; and Department of Dermatology, The County Hospital, Hereford, United Kingdom
| | - E. E. M. Jaeger
- Molecular and Population Genetics Laboratory and Skin Tumour Laboratory, Imperial Cancer Research Fund, Royal London Hospital, and Department of Dermatopathology, St. John's Institute of Dermatology, St. Thomas's Hospital, London; Section of Cancer Genetics, Haddow Laboratories, Institute of Cancer Research, Sutton, United Kingdom; Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford; Department of Dermatology, Queen's Hospital, Burton-on-Trent, United Kingdom; Department of Dermatopharmacology, Southampton University, Southampton, United Kingdom; Department of Dermatology, Orpington Hospital, Orpington, United Kingdom; Department of Dermatology, Queen's Medical Centre, Nottingham; Department of Dermatology, The Queen Elizabeth Hospital, Peterborough, United Kingdom; Department of Dermatology, Leighton Hospital, Crewe, United Kingdom; Summerleas, Yelverton, United Kingdom; Department of Dermatology, Frimley Park Hospital, Frimley, United Kingdom; Department of Dermatology, Southern General Hospital, Glasgow; Department of Dermatology, Watford General Hospital, Watford, United Kingdom; and Department of Dermatology, The County Hospital, Hereford, United Kingdom
| | - H. M. Nelson
- Molecular and Population Genetics Laboratory and Skin Tumour Laboratory, Imperial Cancer Research Fund, Royal London Hospital, and Department of Dermatopathology, St. John's Institute of Dermatology, St. Thomas's Hospital, London; Section of Cancer Genetics, Haddow Laboratories, Institute of Cancer Research, Sutton, United Kingdom; Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford; Department of Dermatology, Queen's Hospital, Burton-on-Trent, United Kingdom; Department of Dermatopharmacology, Southampton University, Southampton, United Kingdom; Department of Dermatology, Orpington Hospital, Orpington, United Kingdom; Department of Dermatology, Queen's Medical Centre, Nottingham; Department of Dermatology, The Queen Elizabeth Hospital, Peterborough, United Kingdom; Department of Dermatology, Leighton Hospital, Crewe, United Kingdom; Summerleas, Yelverton, United Kingdom; Department of Dermatology, Frimley Park Hospital, Frimley, United Kingdom; Department of Dermatology, Southern General Hospital, Glasgow; Department of Dermatology, Watford General Hospital, Watford, United Kingdom; and Department of Dermatology, The County Hospital, Hereford, United Kingdom
| | - E. Healy
- Molecular and Population Genetics Laboratory and Skin Tumour Laboratory, Imperial Cancer Research Fund, Royal London Hospital, and Department of Dermatopathology, St. John's Institute of Dermatology, St. Thomas's Hospital, London; Section of Cancer Genetics, Haddow Laboratories, Institute of Cancer Research, Sutton, United Kingdom; Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford; Department of Dermatology, Queen's Hospital, Burton-on-Trent, United Kingdom; Department of Dermatopharmacology, Southampton University, Southampton, United Kingdom; Department of Dermatology, Orpington Hospital, Orpington, United Kingdom; Department of Dermatology, Queen's Medical Centre, Nottingham; Department of Dermatology, The Queen Elizabeth Hospital, Peterborough, United Kingdom; Department of Dermatology, Leighton Hospital, Crewe, United Kingdom; Summerleas, Yelverton, United Kingdom; Department of Dermatology, Frimley Park Hospital, Frimley, United Kingdom; Department of Dermatology, Southern General Hospital, Glasgow; Department of Dermatology, Watford General Hospital, Watford, United Kingdom; and Department of Dermatology, The County Hospital, Hereford, United Kingdom
| | - A. C. Pembroke
- Molecular and Population Genetics Laboratory and Skin Tumour Laboratory, Imperial Cancer Research Fund, Royal London Hospital, and Department of Dermatopathology, St. John's Institute of Dermatology, St. Thomas's Hospital, London; Section of Cancer Genetics, Haddow Laboratories, Institute of Cancer Research, Sutton, United Kingdom; Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford; Department of Dermatology, Queen's Hospital, Burton-on-Trent, United Kingdom; Department of Dermatopharmacology, Southampton University, Southampton, United Kingdom; Department of Dermatology, Orpington Hospital, Orpington, United Kingdom; Department of Dermatology, Queen's Medical Centre, Nottingham; Department of Dermatology, The Queen Elizabeth Hospital, Peterborough, United Kingdom; Department of Dermatology, Leighton Hospital, Crewe, United Kingdom; Summerleas, Yelverton, United Kingdom; Department of Dermatology, Frimley Park Hospital, Frimley, United Kingdom; Department of Dermatology, Southern General Hospital, Glasgow; Department of Dermatology, Watford General Hospital, Watford, United Kingdom; and Department of Dermatology, The County Hospital, Hereford, United Kingdom
| | - P. S. Friedmann
- Molecular and Population Genetics Laboratory and Skin Tumour Laboratory, Imperial Cancer Research Fund, Royal London Hospital, and Department of Dermatopathology, St. John's Institute of Dermatology, St. Thomas's Hospital, London; Section of Cancer Genetics, Haddow Laboratories, Institute of Cancer Research, Sutton, United Kingdom; Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford; Department of Dermatology, Queen's Hospital, Burton-on-Trent, United Kingdom; Department of Dermatopharmacology, Southampton University, Southampton, United Kingdom; Department of Dermatology, Orpington Hospital, Orpington, United Kingdom; Department of Dermatology, Queen's Medical Centre, Nottingham; Department of Dermatology, The Queen Elizabeth Hospital, Peterborough, United Kingdom; Department of Dermatology, Leighton Hospital, Crewe, United Kingdom; Summerleas, Yelverton, United Kingdom; Department of Dermatology, Frimley Park Hospital, Frimley, United Kingdom; Department of Dermatology, Southern General Hospital, Glasgow; Department of Dermatology, Watford General Hospital, Watford, United Kingdom; and Department of Dermatology, The County Hospital, Hereford, United Kingdom
| | - K. Dalziel
- Molecular and Population Genetics Laboratory and Skin Tumour Laboratory, Imperial Cancer Research Fund, Royal London Hospital, and Department of Dermatopathology, St. John's Institute of Dermatology, St. Thomas's Hospital, London; Section of Cancer Genetics, Haddow Laboratories, Institute of Cancer Research, Sutton, United Kingdom; Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford; Department of Dermatology, Queen's Hospital, Burton-on-Trent, United Kingdom; Department of Dermatopharmacology, Southampton University, Southampton, United Kingdom; Department of Dermatology, Orpington Hospital, Orpington, United Kingdom; Department of Dermatology, Queen's Medical Centre, Nottingham; Department of Dermatology, The Queen Elizabeth Hospital, Peterborough, United Kingdom; Department of Dermatology, Leighton Hospital, Crewe, United Kingdom; Summerleas, Yelverton, United Kingdom; Department of Dermatology, Frimley Park Hospital, Frimley, United Kingdom; Department of Dermatology, Southern General Hospital, Glasgow; Department of Dermatology, Watford General Hospital, Watford, United Kingdom; and Department of Dermatology, The County Hospital, Hereford, United Kingdom
| | - E. Calonje
- Molecular and Population Genetics Laboratory and Skin Tumour Laboratory, Imperial Cancer Research Fund, Royal London Hospital, and Department of Dermatopathology, St. John's Institute of Dermatology, St. Thomas's Hospital, London; Section of Cancer Genetics, Haddow Laboratories, Institute of Cancer Research, Sutton, United Kingdom; Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford; Department of Dermatology, Queen's Hospital, Burton-on-Trent, United Kingdom; Department of Dermatopharmacology, Southampton University, Southampton, United Kingdom; Department of Dermatology, Orpington Hospital, Orpington, United Kingdom; Department of Dermatology, Queen's Medical Centre, Nottingham; Department of Dermatology, The Queen Elizabeth Hospital, Peterborough, United Kingdom; Department of Dermatology, Leighton Hospital, Crewe, United Kingdom; Summerleas, Yelverton, United Kingdom; Department of Dermatology, Frimley Park Hospital, Frimley, United Kingdom; Department of Dermatology, Southern General Hospital, Glasgow; Department of Dermatology, Watford General Hospital, Watford, United Kingdom; and Department of Dermatology, The County Hospital, Hereford, United Kingdom
| | - J. Anderson
- Molecular and Population Genetics Laboratory and Skin Tumour Laboratory, Imperial Cancer Research Fund, Royal London Hospital, and Department of Dermatopathology, St. John's Institute of Dermatology, St. Thomas's Hospital, London; Section of Cancer Genetics, Haddow Laboratories, Institute of Cancer Research, Sutton, United Kingdom; Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford; Department of Dermatology, Queen's Hospital, Burton-on-Trent, United Kingdom; Department of Dermatopharmacology, Southampton University, Southampton, United Kingdom; Department of Dermatology, Orpington Hospital, Orpington, United Kingdom; Department of Dermatology, Queen's Medical Centre, Nottingham; Department of Dermatology, The Queen Elizabeth Hospital, Peterborough, United Kingdom; Department of Dermatology, Leighton Hospital, Crewe, United Kingdom; Summerleas, Yelverton, United Kingdom; Department of Dermatology, Frimley Park Hospital, Frimley, United Kingdom; Department of Dermatology, Southern General Hospital, Glasgow; Department of Dermatology, Watford General Hospital, Watford, United Kingdom; and Department of Dermatology, The County Hospital, Hereford, United Kingdom
| | - P. J. August
- Molecular and Population Genetics Laboratory and Skin Tumour Laboratory, Imperial Cancer Research Fund, Royal London Hospital, and Department of Dermatopathology, St. John's Institute of Dermatology, St. Thomas's Hospital, London; Section of Cancer Genetics, Haddow Laboratories, Institute of Cancer Research, Sutton, United Kingdom; Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford; Department of Dermatology, Queen's Hospital, Burton-on-Trent, United Kingdom; Department of Dermatopharmacology, Southampton University, Southampton, United Kingdom; Department of Dermatology, Orpington Hospital, Orpington, United Kingdom; Department of Dermatology, Queen's Medical Centre, Nottingham; Department of Dermatology, The Queen Elizabeth Hospital, Peterborough, United Kingdom; Department of Dermatology, Leighton Hospital, Crewe, United Kingdom; Summerleas, Yelverton, United Kingdom; Department of Dermatology, Frimley Park Hospital, Frimley, United Kingdom; Department of Dermatology, Southern General Hospital, Glasgow; Department of Dermatology, Watford General Hospital, Watford, United Kingdom; and Department of Dermatology, The County Hospital, Hereford, United Kingdom
| | - M. G. Davies
- Molecular and Population Genetics Laboratory and Skin Tumour Laboratory, Imperial Cancer Research Fund, Royal London Hospital, and Department of Dermatopathology, St. John's Institute of Dermatology, St. Thomas's Hospital, London; Section of Cancer Genetics, Haddow Laboratories, Institute of Cancer Research, Sutton, United Kingdom; Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford; Department of Dermatology, Queen's Hospital, Burton-on-Trent, United Kingdom; Department of Dermatopharmacology, Southampton University, Southampton, United Kingdom; Department of Dermatology, Orpington Hospital, Orpington, United Kingdom; Department of Dermatology, Queen's Medical Centre, Nottingham; Department of Dermatology, The Queen Elizabeth Hospital, Peterborough, United Kingdom; Department of Dermatology, Leighton Hospital, Crewe, United Kingdom; Summerleas, Yelverton, United Kingdom; Department of Dermatology, Frimley Park Hospital, Frimley, United Kingdom; Department of Dermatology, Southern General Hospital, Glasgow; Department of Dermatology, Watford General Hospital, Watford, United Kingdom; and Department of Dermatology, The County Hospital, Hereford, United Kingdom
| | - R. Felix
- Molecular and Population Genetics Laboratory and Skin Tumour Laboratory, Imperial Cancer Research Fund, Royal London Hospital, and Department of Dermatopathology, St. John's Institute of Dermatology, St. Thomas's Hospital, London; Section of Cancer Genetics, Haddow Laboratories, Institute of Cancer Research, Sutton, United Kingdom; Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford; Department of Dermatology, Queen's Hospital, Burton-on-Trent, United Kingdom; Department of Dermatopharmacology, Southampton University, Southampton, United Kingdom; Department of Dermatology, Orpington Hospital, Orpington, United Kingdom; Department of Dermatology, Queen's Medical Centre, Nottingham; Department of Dermatology, The Queen Elizabeth Hospital, Peterborough, United Kingdom; Department of Dermatology, Leighton Hospital, Crewe, United Kingdom; Summerleas, Yelverton, United Kingdom; Department of Dermatology, Frimley Park Hospital, Frimley, United Kingdom; Department of Dermatology, Southern General Hospital, Glasgow; Department of Dermatology, Watford General Hospital, Watford, United Kingdom; and Department of Dermatology, The County Hospital, Hereford, United Kingdom
| | - C. S. Munro
- Molecular and Population Genetics Laboratory and Skin Tumour Laboratory, Imperial Cancer Research Fund, Royal London Hospital, and Department of Dermatopathology, St. John's Institute of Dermatology, St. Thomas's Hospital, London; Section of Cancer Genetics, Haddow Laboratories, Institute of Cancer Research, Sutton, United Kingdom; Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford; Department of Dermatology, Queen's Hospital, Burton-on-Trent, United Kingdom; Department of Dermatopharmacology, Southampton University, Southampton, United Kingdom; Department of Dermatology, Orpington Hospital, Orpington, United Kingdom; Department of Dermatology, Queen's Medical Centre, Nottingham; Department of Dermatology, The Queen Elizabeth Hospital, Peterborough, United Kingdom; Department of Dermatology, Leighton Hospital, Crewe, United Kingdom; Summerleas, Yelverton, United Kingdom; Department of Dermatology, Frimley Park Hospital, Frimley, United Kingdom; Department of Dermatology, Southern General Hospital, Glasgow; Department of Dermatology, Watford General Hospital, Watford, United Kingdom; and Department of Dermatology, The County Hospital, Hereford, United Kingdom
| | - M. Murdoch
- Molecular and Population Genetics Laboratory and Skin Tumour Laboratory, Imperial Cancer Research Fund, Royal London Hospital, and Department of Dermatopathology, St. John's Institute of Dermatology, St. Thomas's Hospital, London; Section of Cancer Genetics, Haddow Laboratories, Institute of Cancer Research, Sutton, United Kingdom; Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford; Department of Dermatology, Queen's Hospital, Burton-on-Trent, United Kingdom; Department of Dermatopharmacology, Southampton University, Southampton, United Kingdom; Department of Dermatology, Orpington Hospital, Orpington, United Kingdom; Department of Dermatology, Queen's Medical Centre, Nottingham; Department of Dermatology, The Queen Elizabeth Hospital, Peterborough, United Kingdom; Department of Dermatology, Leighton Hospital, Crewe, United Kingdom; Summerleas, Yelverton, United Kingdom; Department of Dermatology, Frimley Park Hospital, Frimley, United Kingdom; Department of Dermatology, Southern General Hospital, Glasgow; Department of Dermatology, Watford General Hospital, Watford, United Kingdom; and Department of Dermatology, The County Hospital, Hereford, United Kingdom
| | - J. Rendall
- Molecular and Population Genetics Laboratory and Skin Tumour Laboratory, Imperial Cancer Research Fund, Royal London Hospital, and Department of Dermatopathology, St. John's Institute of Dermatology, St. Thomas's Hospital, London; Section of Cancer Genetics, Haddow Laboratories, Institute of Cancer Research, Sutton, United Kingdom; Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford; Department of Dermatology, Queen's Hospital, Burton-on-Trent, United Kingdom; Department of Dermatopharmacology, Southampton University, Southampton, United Kingdom; Department of Dermatology, Orpington Hospital, Orpington, United Kingdom; Department of Dermatology, Queen's Medical Centre, Nottingham; Department of Dermatology, The Queen Elizabeth Hospital, Peterborough, United Kingdom; Department of Dermatology, Leighton Hospital, Crewe, United Kingdom; Summerleas, Yelverton, United Kingdom; Department of Dermatology, Frimley Park Hospital, Frimley, United Kingdom; Department of Dermatology, Southern General Hospital, Glasgow; Department of Dermatology, Watford General Hospital, Watford, United Kingdom; and Department of Dermatology, The County Hospital, Hereford, United Kingdom
| | - S. Kennedy
- Molecular and Population Genetics Laboratory and Skin Tumour Laboratory, Imperial Cancer Research Fund, Royal London Hospital, and Department of Dermatopathology, St. John's Institute of Dermatology, St. Thomas's Hospital, London; Section of Cancer Genetics, Haddow Laboratories, Institute of Cancer Research, Sutton, United Kingdom; Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford; Department of Dermatology, Queen's Hospital, Burton-on-Trent, United Kingdom; Department of Dermatopharmacology, Southampton University, Southampton, United Kingdom; Department of Dermatology, Orpington Hospital, Orpington, United Kingdom; Department of Dermatology, Queen's Medical Centre, Nottingham; Department of Dermatology, The Queen Elizabeth Hospital, Peterborough, United Kingdom; Department of Dermatology, Leighton Hospital, Crewe, United Kingdom; Summerleas, Yelverton, United Kingdom; Department of Dermatology, Frimley Park Hospital, Frimley, United Kingdom; Department of Dermatology, Southern General Hospital, Glasgow; Department of Dermatology, Watford General Hospital, Watford, United Kingdom; and Department of Dermatology, The County Hospital, Hereford, United Kingdom
| | - I. M. Leigh
- Molecular and Population Genetics Laboratory and Skin Tumour Laboratory, Imperial Cancer Research Fund, Royal London Hospital, and Department of Dermatopathology, St. John's Institute of Dermatology, St. Thomas's Hospital, London; Section of Cancer Genetics, Haddow Laboratories, Institute of Cancer Research, Sutton, United Kingdom; Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford; Department of Dermatology, Queen's Hospital, Burton-on-Trent, United Kingdom; Department of Dermatopharmacology, Southampton University, Southampton, United Kingdom; Department of Dermatology, Orpington Hospital, Orpington, United Kingdom; Department of Dermatology, Queen's Medical Centre, Nottingham; Department of Dermatology, The Queen Elizabeth Hospital, Peterborough, United Kingdom; Department of Dermatology, Leighton Hospital, Crewe, United Kingdom; Summerleas, Yelverton, United Kingdom; Department of Dermatology, Frimley Park Hospital, Frimley, United Kingdom; Department of Dermatology, Southern General Hospital, Glasgow; Department of Dermatology, Watford General Hospital, Watford, United Kingdom; and Department of Dermatology, The County Hospital, Hereford, United Kingdom
| | - D. P. Kelsell
- Molecular and Population Genetics Laboratory and Skin Tumour Laboratory, Imperial Cancer Research Fund, Royal London Hospital, and Department of Dermatopathology, St. John's Institute of Dermatology, St. Thomas's Hospital, London; Section of Cancer Genetics, Haddow Laboratories, Institute of Cancer Research, Sutton, United Kingdom; Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford; Department of Dermatology, Queen's Hospital, Burton-on-Trent, United Kingdom; Department of Dermatopharmacology, Southampton University, Southampton, United Kingdom; Department of Dermatology, Orpington Hospital, Orpington, United Kingdom; Department of Dermatology, Queen's Medical Centre, Nottingham; Department of Dermatology, The Queen Elizabeth Hospital, Peterborough, United Kingdom; Department of Dermatology, Leighton Hospital, Crewe, United Kingdom; Summerleas, Yelverton, United Kingdom; Department of Dermatology, Frimley Park Hospital, Frimley, United Kingdom; Department of Dermatology, Southern General Hospital, Glasgow; Department of Dermatology, Watford General Hospital, Watford, United Kingdom; and Department of Dermatology, The County Hospital, Hereford, United Kingdom
| | - I. P. M. Tomlinson
- Molecular and Population Genetics Laboratory and Skin Tumour Laboratory, Imperial Cancer Research Fund, Royal London Hospital, and Department of Dermatopathology, St. John's Institute of Dermatology, St. Thomas's Hospital, London; Section of Cancer Genetics, Haddow Laboratories, Institute of Cancer Research, Sutton, United Kingdom; Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford; Department of Dermatology, Queen's Hospital, Burton-on-Trent, United Kingdom; Department of Dermatopharmacology, Southampton University, Southampton, United Kingdom; Department of Dermatology, Orpington Hospital, Orpington, United Kingdom; Department of Dermatology, Queen's Medical Centre, Nottingham; Department of Dermatology, The Queen Elizabeth Hospital, Peterborough, United Kingdom; Department of Dermatology, Leighton Hospital, Crewe, United Kingdom; Summerleas, Yelverton, United Kingdom; Department of Dermatology, Frimley Park Hospital, Frimley, United Kingdom; Department of Dermatology, Southern General Hospital, Glasgow; Department of Dermatology, Watford General Hospital, Watford, United Kingdom; and Department of Dermatology, The County Hospital, Hereford, United Kingdom
| | - R. S. Houlston
- Molecular and Population Genetics Laboratory and Skin Tumour Laboratory, Imperial Cancer Research Fund, Royal London Hospital, and Department of Dermatopathology, St. John's Institute of Dermatology, St. Thomas's Hospital, London; Section of Cancer Genetics, Haddow Laboratories, Institute of Cancer Research, Sutton, United Kingdom; Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford; Department of Dermatology, Queen's Hospital, Burton-on-Trent, United Kingdom; Department of Dermatopharmacology, Southampton University, Southampton, United Kingdom; Department of Dermatology, Orpington Hospital, Orpington, United Kingdom; Department of Dermatology, Queen's Medical Centre, Nottingham; Department of Dermatology, The Queen Elizabeth Hospital, Peterborough, United Kingdom; Department of Dermatology, Leighton Hospital, Crewe, United Kingdom; Summerleas, Yelverton, United Kingdom; Department of Dermatology, Frimley Park Hospital, Frimley, United Kingdom; Department of Dermatology, Southern General Hospital, Glasgow; Department of Dermatology, Watford General Hospital, Watford, United Kingdom; and Department of Dermatology, The County Hospital, Hereford, United Kingdom
| |
Collapse
|